Summary & Overview
CPT 53860: Endoluminal Radiofrequency Treatment for Stress Continence
CPT code 53860 denotes an endoluminal, minimally invasive radiofrequency procedure for stress urinary incontinence that reduces tissue elasticity through collagen denaturation. The code is nationally relevant as an alternative to more invasive surgical continence interventions, with implications for procedure site selection, device coverage, and outpatient care pathways. Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn what CPT code 53860 represents clinically, typical sites of service, and which major payers are referenced in payer policy discussions. The publication outlines benchmarks and payment considerations where available, summarizes clinical context for use of radiofrequency denaturation in stress continence, and highlights policy and coding items that affect billing and coverage decisions. Data not available in the input is noted when specific benchmarking, associated taxonomies, ICD-10 diagnosis links, and related codes are absent.
Billing Code Overview
CPT code 53860 describes a minimally invasive, endoluminal radiofrequency procedure to treat stress urinary incontinence. In this treatment, a probe with a balloon tip is inserted into the bladder lumen and controlled radiofrequency energy is delivered to the bladder neck and adjacent tissues to denature collagen and reduce local tissue elasticity.
-
Service type: Minimally invasive therapeutic procedure using radiofrequency energy for urinary continence
-
Typical site of service: Ambulatory surgery center or hospital outpatient setting; procedure requires endoluminal access to the bladder and specialized equipment
Clinical & Coding Specifications
Clinical Context
A typical patient is a symptomatic adult female with stress urinary incontinence (SUI) who has failed or prefers to avoid conservative measures such as pelvic floor physical therapy, pessary use, or behavioral modification. The patient reports involuntary urine leakage with exertion, coughing, or sneezing. Pre-procedure evaluation includes medical history, focused pelvic exam, urinalysis to exclude infection, and assessment of pelvic floor support and urethral mobility. Counseling covers procedural risks, benefits, and alternatives. The procedure is performed in an ambulatory surgery center or office-based procedure room under local anesthesia with or without sedation, sometimes in an operating room for patients requiring monitored anesthesia care. A specialized urologist or urogynecologist places a transurethral balloon-tipped probe into the bladder lumen and delivers controlled radiofrequency energy to the submucosal tissues of the bladder neck/urethra to denature collagen and reduce tissue elasticity. Typical peri-procedural workflow includes informed consent, anesthesia/sedation management, sterile field setup, cystoscopic or cystoscopic-guided placement of the device, staged delivery of radiofrequency at defined loci, brief recovery observation, voiding trial as indicated, and post-procedure discharge instructions for activity, voiding, and signs of complications.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Normal or default service | Use when service is performed as described without unusual circumstances. |